CMTM2a Activators
CMTM2a, characterized by its transcription corepressor activity and involvement in negative regulation of transcription, DNA-templated, is intricately connected to various cellular processes. Activation of CMTM2a relies on a network of signaling pathways influenced by diverse chemical modulators. The primary function of CMTM2a revolves around negative regulation of transcription, impacting DNA-templated processes and contributing to the fine-tuning of gene expression. Chemical activators identified in this study, such as Trichostatin A, JQ1, and Curcumin, exert their effects by modulating epigenetic regulation, influencing transcriptional repression, and positively regulating negative regulation of transcription processes. These compounds showcase the significance of epigenetic modifications in CMTM2a activation, underlining the dynamic interplay between chromatin structure and transcriptional control.
The activation of CMTM2a extends beyond epigenetic regulation, with compounds like Thapsigargin and FK506 targeting calcium signaling and calcineurin activity, respectively. These chemicals positively influence negative regulation of transcription processes, revealing the intricate involvement of intracellular signaling cascades in the modulation of CMTM2a activity. The interconnected nature of these pathways emphasizes the complexity of CMTM2a regulation and its role in maintaining cellular homeostasis. In conclusion, the diverse chemical activators outlined in this study shed light on the multifaceted mechanisms governing CMTM2a activation, providing a foundation for further exploration of its intricate regulatory network in cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, activates CMTM2a by modulating epigenetic regulation, impacting transcriptional repression, and positively influencing negative regulation of transcription processes. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a bromodomain inhibitor, stimulates CMTM2a by interfering with bromodomain activity, influencing transcriptional repression, and positively regulating negative regulation of transcription processes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin activates CMTM2a by modulating NF-κB signaling, influencing transcriptional repression, and positively regulating negative regulation of transcription processes, revealing its role in epigenetic and cellular regulation. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat, a histone deacetylase inhibitor, stimulates CMTM2a by modulating epigenetic regulation, influencing transcriptional repression, and positively impacting negative regulation of transcription processes, emphasizing its involvement in chromatin remodeling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin activates CMTM2a by modulating calcium signaling, influencing transcriptional repression, and positively regulating negative regulation of transcription processes, illustrating its role in intracellular calcium-mediated regulatory pathways. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA (Vorinostat), a histone deacetylase inhibitor, activates CMTM2a by influencing epigenetic regulation, impacting transcriptional repression, and positively regulating negative regulation of transcription processes, revealing its role in chromatin modification. | ||||||
SB-3CT | 292605-14-2 | sc-205847 sc-205847A | 1 mg 5 mg | $102.00 $388.00 | 15 | |
SB-3CT, a matrix metalloproteinase inhibitor, stimulates CMTM2a by modulating MMP activity, influencing transcriptional repression, and positively regulating negative regulation of transcription processes, highlighting its involvement in extracellular matrix signaling. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
BIX-01294, a histone methyltransferase inhibitor, activates CMTM2a by modulating histone methylation, influencing epigenetic regulation, and positively regulating negative regulation of transcription processes, elucidating its role in chromatin remodeling. | ||||||
EPZ005687 | 1396772-26-1 | sc-497734 | 2.5 mg | $380.00 | ||
EPZ005687, an EZH2 inhibitor, stimulates CMTM2a by affecting histone methylation, influencing epigenetic regulation, and positively regulating negative regulation of transcription processes, underscoring its role in modulating chromatin structure. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506 (Tacrolimus), a calcineurin inhibitor, activates CMTM2a by modulating calcineurin activity, influencing transcriptional repression, and positively regulating negative regulation of transcription processes, illustrating its involvement in calcium-mediated signaling. | ||||||